Effects of bosentan on peripheral endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension

Abstract. Endothelin receptor antagonists (ERAs) have been shown to improve the prognosis of patients with pulmonary arterial hypertension (PAH). However, the effect of the oral dual ERA bosentan on peripheral endothelial dysfunction (PED), as assessed by flow-mediated vasodilation (FMD), in patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pulm Circ
Main Authors: Hirashiki, Akihiro, Adachi, Shiro, Nakano, Yoshihisa, Kamimura, Yoshihiro, Shimokata, Shigetake, Takeshita, Kyosuke, Murohara, Toyoaki, Kondo, Takahisa
Formato: Artigo
Idioma:Inglês
Publicado em: University of Chicago Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869920/
https://ncbi.nlm.nih.gov/pubmed/27252842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685715
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados